MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Merck & Co., Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$143.63−2.32 (-1.59%)
Close on Oct 19, 2026
- Market cap
- $354.77B
- P/E (TTM)
- 114.9
- Dividend yield
- 2.28%
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Feb 17, 1999 | 2-for-1 | Earlier per-share figures divided by 2 |
| May 26, 1992 | 3-for-1 | Earlier per-share figures divided by 3 |
| May 26, 1988 | 3-for-1 | Earlier per-share figures divided by 3 |
| May 27, 1986 | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 1, 1972 | 2-for-1 | Earlier per-share figures divided by 2 |
| May 27, 1964 | 3-for-1 | Earlier per-share figures divided by 3 |